CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Open-market sale CFO, Secretary and Treasurer sold 22,790 shares at $11.21 ($255,476)
- 4/A Grant or award WEISS MICHAEL S acquired 672,343 shares (grant or award)
- 4 Grant or award CFO, Secretary and Treasurer acquired 50,000 shares (grant or award)
- 4 Grant or award WEISS MICHAEL S acquired 6,723,443 shares (grant or award)
- 4 Open-market sale Director sold 17,000 shares at $17.08 ($290,360)
- 4 Open-market sale CFO, Secretary and Treasurer sold 50,054 shares at $16.46 ($823,889)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 4,667 shares (grant or award)
- 4 Grant or award Director acquired 4,667 shares (grant or award)
- 4 Grant or award Director acquired 4,667 shares (grant or award)
- 4 Grant or award Director acquired 4,667 shares (grant or award)
- 4 Grant or award WEISS MICHAEL S acquired 337,257 shares (grant or award)
- 4 Grant or award Director acquired 4,667 shares (grant or award)
- 4 Open-market buy 10% owner bought 114,855 shares at $6.53 ($750,003)
- 4 Open-market sale CFO, Secretary and Treasurer sold 23,800 shares at an average $15.50 ($369,010)
- 4 Open-market sale CFO, Secretary and Treasurer sold 66,401 shares at an average $16.40 ($1,088,890)
- 4 Grant or award CFO, Secretary and Treasurer acquired 10,000 shares (grant or award)
- 4 Grant or award WEISS MICHAEL S acquired 268,603 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale WEISS MICHAEL S sold 210,618 shares at $16.44 ($3,462,560)
Page 7 of 18 · 353 filings